A detailed history of Fmr LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 1,038,307 shares of FOLD stock, worth $11.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,038,307
Previous 1,747,546 40.58%
Holding current value
$11.3 Million
Previous $20.6 Million 49.97%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$9.04 - $11.75 $6.41 Million - $8.33 Million
-709,239 Reduced 40.58%
1,038,307 $10.3 Million
Q1 2024

May 13, 2024

SELL
$11.43 - $14.24 $5.11 Million - $6.36 Million
-446,914 Reduced 20.37%
1,747,546 $20.6 Million
Q4 2023

Feb 13, 2024

SELL
$9.97 - $14.52 $5.82 Million - $8.48 Million
-583,772 Reduced 21.01%
2,194,460 $31.1 Million
Q3 2023

Nov 13, 2023

BUY
$11.78 - $13.86 $5.52 Million - $6.49 Million
468,611 Added 20.29%
2,778,232 $33.8 Million
Q2 2023

Aug 11, 2023

BUY
$10.72 - $13.3 $1.1 Million - $1.36 Million
102,383 Added 4.64%
2,309,621 $29 Million
Q1 2023

May 11, 2023

SELL
$10.91 - $13.54 $3.1 Million - $3.85 Million
-284,410 Reduced 11.41%
2,207,238 $24.5 Million
Q4 2022

Feb 13, 2023

SELL
$9.89 - $12.7 $2.99 Million - $3.84 Million
-302,420 Reduced 10.82%
2,491,648 $30.4 Million
Q3 2022

Nov 10, 2022

BUY
$9.82 - $12.75 $7.31 Million - $9.49 Million
744,451 Added 36.32%
2,794,068 $29.2 Million
Q2 2022

Aug 12, 2022

BUY
$6.23 - $11.12 $2.11 Million - $3.76 Million
338,528 Added 19.78%
2,049,617 $22 Million
Q1 2022

May 13, 2022

BUY
$7.89 - $12.48 $877,817 - $1.39 Million
111,257 Added 6.95%
1,711,089 $16.2 Million
Q4 2021

Feb 14, 2022

BUY
$9.82 - $12.44 $2.9 Million - $3.68 Million
295,700 Added 22.67%
1,599,832 $18.5 Million
Q2 2021

Aug 13, 2021

BUY
$8.71 - $10.72 $11.4 Million - $14 Million
1,304,132 New
1,304,132 $12.6 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $3.06B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.